Search research articles
Contact Us
Filters
Showing results (21-30 of 44) with videos related to
Page
of 5
Sort By:
Therapeutic Innovation & Regulatory Science
|
February 10, 2026
Evaluating Post-Progression Survival in the Context of Progression-Free Survival Benefits: A Revisit of the CodeBreaK200 Design
Zhoujingpeng Wei, Yuanyuan Han, Luoying Yang, et al.
PPAR Research
|
November 21, 2025
To Explore the Active Components, Targets, and Potential Effects of Emodin in the Treatment of Colorectal Cancer Based on Network Pharmacology
Libin Chen, Jiante Li, Zhicheng Cheng, et al.
Advanced Healthcare Materials
|
July 27, 2019
Multitargeted Nanoparticles Deliver Synergistic Drugs across the Blood-Brain Barrier to Brain Metastases of Triple Negative Breast Cancer Cells and Tumor-Associated Macrophages
Tian Zhang, Hoyin Lip, Chunsheng He, et al.
Clinical Pharmacology and Therapeutics
|
February 27, 2025
Assessing Correlation between Surrogate Endpoints and Overall Survival for Oncology Clinical Trials
Guotao Chu, Xiaochen Zhu, Jiaju Wu, et al.
Materials Today. Bio
|
September 2, 2024
Targeting DNA damage repair mechanism by using RAD50-silencing siRNA nanoparticles to enhance radiotherapy in triple negative breast cancer
Abdulmottaleb E Zetrini, Azhar Z Abbasi, Chunsheng He, et al.
Journal of Controlled Release : Official Journal of the Controlled Release Society
|
November 30, 2024
Nanoparticulate drug combination inhibits DNA damage repair and PD-L1 expression in BRCA-mutant and wild type triple-negative breast cancer
Ibrahim Alradwan, Pei Zhi, Tian Zhang, et al.
Journal of Controlled Release : Official Journal of the Controlled Release Society
|
December 27, 2016
Blood-brain barrier-penetrating amphiphilic polymer nanoparticles deliver docetaxel for the treatment of brain metastases of triple negative breast cancer
Chunsheng He, Ping Cai, Jason Li, et al.
Materials Today. Bio
|
November 19, 2025
Empowering chemotherapy-induced antitumor immunity by multi-targeted synergistic combination nanomedicine for triple-negative breast cancer
Ibrahim Alradwan, Pei Zhi, Abdulmottaleb E Zetrini, et al.
Research (Washington, D.C.)
|
October 5, 2023
Remodeling Tumor Immune Microenvironment by Using Polymer-Lipid-Manganese Dioxide Nanoparticles with Radiation Therapy to Boost Immune Response of Castration-Resistant Prostate Cancer
Abdulmottaleb E Zetrini, HoYin Lip, Azhar Z Abbasi, et al.
Journal of Controlled Release : Official Journal of the Controlled Release Society
|
April 25, 2015
Manganese oxide and docetaxel co-loaded fluorescent polymer nanoparticles for dual modal imaging and chemotherapy of breast cancer
Azhar Z Abbasi, Preethy Prasad, Ping Cai, et al.
Page
of 5
Search research articles
Search
Showing results (21-30 of 44) with videos related to
Sort By:
Page
of 5
Therapeutic Innovation & Regulatory Science
|
February 10, 2026
Evaluating Post-Progression Survival in the Context of Progression-Free Survival Benefits: A Revisit of the CodeBreaK200 Design
Zhoujingpeng Wei, Yuanyuan Han, Luoying Yang, et al.
PPAR Research
|
November 21, 2025
To Explore the Active Components, Targets, and Potential Effects of Emodin in the Treatment of Colorectal Cancer Based on Network Pharmacology
Libin Chen, Jiante Li, Zhicheng Cheng, et al.
Advanced Healthcare Materials
|
July 27, 2019
Multitargeted Nanoparticles Deliver Synergistic Drugs across the Blood-Brain Barrier to Brain Metastases of Triple Negative Breast Cancer Cells and Tumor-Associated Macrophages
Tian Zhang, Hoyin Lip, Chunsheng He, et al.
Clinical Pharmacology and Therapeutics
|
February 27, 2025
Assessing Correlation between Surrogate Endpoints and Overall Survival for Oncology Clinical Trials
Guotao Chu, Xiaochen Zhu, Jiaju Wu, et al.
Materials Today. Bio
|
September 2, 2024
Targeting DNA damage repair mechanism by using RAD50-silencing siRNA nanoparticles to enhance radiotherapy in triple negative breast cancer
Abdulmottaleb E Zetrini, Azhar Z Abbasi, Chunsheng He, et al.
Journal of Controlled Release : Official Journal of the Controlled Release Society
|
November 30, 2024
Nanoparticulate drug combination inhibits DNA damage repair and PD-L1 expression in BRCA-mutant and wild type triple-negative breast cancer
Ibrahim Alradwan, Pei Zhi, Tian Zhang, et al.
Journal of Controlled Release : Official Journal of the Controlled Release Society
|
December 27, 2016
Blood-brain barrier-penetrating amphiphilic polymer nanoparticles deliver docetaxel for the treatment of brain metastases of triple negative breast cancer
Chunsheng He, Ping Cai, Jason Li, et al.
Materials Today. Bio
|
November 19, 2025
Empowering chemotherapy-induced antitumor immunity by multi-targeted synergistic combination nanomedicine for triple-negative breast cancer
Ibrahim Alradwan, Pei Zhi, Abdulmottaleb E Zetrini, et al.
Research (Washington, D.C.)
|
October 5, 2023
Remodeling Tumor Immune Microenvironment by Using Polymer-Lipid-Manganese Dioxide Nanoparticles with Radiation Therapy to Boost Immune Response of Castration-Resistant Prostate Cancer
Abdulmottaleb E Zetrini, HoYin Lip, Azhar Z Abbasi, et al.
Journal of Controlled Release : Official Journal of the Controlled Release Society
|
April 25, 2015
Manganese oxide and docetaxel co-loaded fluorescent polymer nanoparticles for dual modal imaging and chemotherapy of breast cancer
Azhar Z Abbasi, Preethy Prasad, Ping Cai, et al.
Page
of 5